Conference Collaborators

1.  What is your organisation hoping to achieve by attending the conference?

The AVHC is the best forum to discover the novel approaches being used to advance the elimination of viral hepatitis, including community led approaches, public health innovations, and the latest clinical and scientific advances. It is the one conference where a diverse and multidisciplinary sector can gather to share ideas, challenges, and successes from across Australia, New Zealand, and internationally.

2. Why do you think it is a benefit for your staff to attend the conference?

A real strength of the AVHC is the diversity in terms of research, policy and programs presented, and in terms of the skills and backgrounds of all delegates. Our team is continually challenged and inspired at the AVHC, and to really consider how our day-to-day work fits within the broad range of efforts across the entire sector. We always come away with new ideas, new priorities, and renewed enthusiasm and sense of purpose. It’s the one conference we all try to never miss!

3. What topics are you looking forward to hearing about the most at the conference?

We are excited to hear about innovative approaches to scaling up access to treatment and care of viral hepatitis in all settings, especially in primary care; to discuss new ways of estimating the burden of viral hepatitis in Australasia and the development of monitoring and evaluation systems to track our progress; and to hear about ways affected communities are being engaged and supported to assume leadership of the viral hepatitis elimination agenda. These insights will be essential to ensure that nobody is left behind in our own countries, but also across our region and globally.

The Hepatitis Foundation of NZ is committed to meeting the WHO Elimination of Viral Hepatitis Targets by 2030.  By attending the AVH Conference the Foundation staff can share knowledge and experiences with our colleagues as well as understanding  new ways of working.  In particular, hearing from those people who have experienced stigma and discrimination living with viral hepatitis and how we might learn from those lived experiences to ensure 'no one is left behind'.

1.  What is your organisation hoping to achieve by attending the conference?

Health departments are responsible for setting policy and programmatic responses to viral hepatitis and identifying resource priorities. The Viral Hepatitis Conference offers the latest research and reflection on initiatives underway In Australasian region to assist departmental planning.

2. Why do you think it is a benefit for your staff to attend the conference?

Staff working in health departments attend the Viral Hepatitis Conference to ensure they are across the latest research and participating in discussions about viral hepatitis elimination goals. This builds an evidence base for planning policy and program moving forward.

3.What topics are you looking forward to hearing about the most at the conference?

We are all excited about reaching goals to eliminate hepatitis C. This Viral Hepatitis Conference theme of leaving no one behind is a critical factor in realising the elimination target. Hepatitis B remains a challenge on many levels and we look forward to advances in policy and programs for populations affected by the hepatitis B virus.

1.  What is your organisation hoping to achieve by attending the conference?

ASID wants to showcase the breadth of research and innovation in viral hepatitis coming from Australian experts.  AVHC brings together researchers with diverse backgrounds - clinicians, health professionals, researchers, community, policy makers, advocates - which makes it particularly informative. 

2. Why do you think it is a benefit for your staff to attend the conference?

Australia has clinical and research expertise in viral hepatitis, with strong community engagement and public health policies that are leading the world. Delegates to the conference will be able to learn from different approaches across Australia to these infectious diseases.

3.What topics are you looking forward to hearing about the most at the conference?

Progress towards hepatitis elimination in Australia and the region will be very topical. We need to develop a set of milestones that will help all of us know what elimination means, how to get there and how to sharpen our response when we go off track. 

1.  What is your organisation hoping to achieve by attending the conference?

The Australasian Viral Hepatitis Conference provides the key local forum to share research and practice innovation in viral hepatitis. As a major contributor to research and program implementation around viral hepatitis in Australia, the Burnet Institute values highly the opportunity to inform others’ work and also learn from the activities of other groups in Australia and internationally.   

2. Why do you think it is a benefit for your staff to attend the conference?

The collaboration and partnership building opportunities afforded by the Australasian Viral Hepatitis Conference are crucial for both senior and emerging researchers at the Burnet Institute. The conference provides a key opportunity to build and maintain sector relationships across Australian jurisdictions and among those visiting from overseas.

3.What topics are you looking forward to hearing about the most at the conference?

The opportunity to hear about adaptive models of care for viral hepatitis within the context of the overall theme of the conference, no one left behind, is exciting. The success of Australia’s response to viral hepatitis over coming years will hinge on our ability adopt innovative responses to delivering care into community settings. Seeing the different ways people are responding to this challenge will be great for informing our work and will foster collaboration opportunities.

  1. What is your organisation hoping to achieve by attending the conference?

Australia has clinical and research expertise in viral hepatitis, with strong community engagement and world-leading public health policy.  The Australasian Viral Hepatitis Conference provides a wonderful opportunity for academics, clinicians, community members and policy makers, to present and discuss topical issues related to viral hepatitis.  The conference showcases the breadth of research innovation in viral hepatitis relevant to our region.

  1. Why do you think it is a benefit for your staff to attend the conference?

For the Kirby Institute, this is an important meeting, facilitating collaboration and exchange of ideas, across borders, disciplines and career stages.  

  1. What topics are you looking forward to hearing about the most at the conference?

In light of the 2030 Sustainable Development Goals, the Kirby Institute is looking forward to sharing and hearing about novel testing, diagnosis, treatment and prevention strategies in the region, as we strive to eliminate viral hepatitis as a public health threat.